Avalo Therapeutics, Inc. (AVTX) SEC Filings https://ir.avalotx.com/sec-filings/annual-reports/rss Avalo Therapeutics, Inc. (AVTX) - Annual reports en-us https://d1io3yog0oux5.cloudfront.net/_ea697aa916e28469528b0006da59afb9/avalotx/files/theme/images/logo-sm.png Avalo Therapeutics, Inc. Logo Equisolve Investor Relations Suite <![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]> https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001534120-26-000011/0001534120-26-000011.pdf Mon, 23 Mar 26 00:00:00 -0400 https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001534120-26-000011/0001534120-26-000011.pdf <![CDATA[ARS - Annual Report to Security Holders]]> https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001628280-25-021315/0001628280-25-021315.pdf Thu, 01 May 25 00:00:00 -0400 https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001628280-25-021315/0001628280-25-021315.pdf <![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]> https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001628280-25-013986/0001628280-25-013986.pdf Thu, 20 Mar 25 00:00:00 -0400 https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001628280-25-013986/0001628280-25-013986.pdf <![CDATA[ARS - Annual report to security holders]]> https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001628280-24-030234/0001628280-24-030234.pdf Thu, 27 Jun 24 00:00:00 -0400 https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001628280-24-030234/0001628280-24-030234.pdf <![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]> https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001628280-24-013786/0001628280-24-013786.pdf Fri, 29 Mar 24 00:00:00 -0400 https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001628280-24-013786/0001628280-24-013786.pdf <![CDATA[ARS - Annual report to security holders]]> https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001628280-23-034696/0001628280-23-034696.pdf Thu, 19 Oct 23 00:00:00 -0400 https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001628280-23-034696/0001628280-23-034696.pdf <![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]> https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001628280-23-009630/0001628280-23-009630.pdf Wed, 29 Mar 23 00:00:00 -0400 https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001628280-23-009630/0001628280-23-009630.pdf <![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]> https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001628280-22-004671/0001628280-22-004671.pdf Wed, 02 Mar 22 00:00:00 -0500 https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001628280-22-004671/0001628280-22-004671.pdf <![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]> https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001628280-21-004162/0001628280-21-004162.pdf Mon, 08 Mar 21 00:00:00 -0500 https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001628280-21-004162/0001628280-21-004162.pdf <![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]> https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001628280-20-003395/0001628280-20-003395.pdf Wed, 11 Mar 20 00:00:00 -0400 https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001628280-20-003395/0001628280-20-003395.pdf